Disease burden of breast cancer in Hong Kong: an exploration of trends for screening policy and resource allocation by Leung, GM et al.
Title Disease burden of breast cancer in Hong Kong: an explorationof trends for screening policy and resource allocation
Author(s) Wong, OL; Schooling, CM; Cowling, BJ; Wong, CN; Leung, GM
Citation Hong Kong Medical Journal, 2016, v. 22 n. 6, suppl. 6, p. 4-7
Issued Date 2016
URL http://hdl.handle.net/10722/244564
Rights
Hong Kong Medical Journal. Copyright © Hong Kong Academy
of Medicine Press.; This work is licensed under a Creative
Commons Attribution-NonCommercial-NoDerivatives 4.0
International License.
4 Hong Kong Med J  ⎥  Volume 22 Number 6 (Supplement 6)  ⎥  December 2016  ⎥  www.hkmj.org Hong Kong Med J  ⎥  Volume 22 Number 6 (Supplement 6)  ⎥  December 2016  ⎥  www.hkmj.org
K e y  M e s s a g e s 
1. The increased risk in breast cancer incidence 
has continued, likely owing to ageing and cohort 
effects. Nonetheless, breast cancer mortality has 
remained stable during the past three decades 
despite some increased projections in older 
women.
2. Future research to investigate the underlying 
reasons for the increased projections for older 
women is warranted. 
3. Strong birth cohort trends in breast cancer 
incidence and mortality are observed.
4. Some birth cohorts have a higher risk of 
developing breast cancer but a lower chance 
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Introduction
Breast cancer is the most common malignancy and 
the leading cause of cancer-related death in women, 
accounting for 10% of new malignancies worldwide 
annually, and ~22% of all female malignancies.1 In 
Hong Kong, breast cancer is the most common 
cancer and the third leading cause of cancer-related 
mortality among women, with an age-standardised 
incidence and mortality of 61.0 and 9.1 per 100 000 
in 2011, respectively.2 The incidence in Hong Kong is 
rising and exceeding all other East Asian populations 
except Singapore.1 Nonetheless, the death rate in 
Hong Kong has been stable over the past three 
decades.2
 Age-period-cohort (APC) models have 
been used to examine trends in the incidence and 
mortality over time as well as different biological and 
environmental causes of cancer.3 Hong Kong has a 
history of rapid economic transitions over the past 
60 years. Within two to three generations, Hong 
Kong has transformed from a third-world economy 
to a major financial centre. Socio-economic 
development is often followed by improved living 
standard and clinical interventions that are expected 
to affect the incidence and mortality of breast cancer. 
The economic and socio-cultural context of Hong 
Kong serves as a natural testing ground to examine 
how contextual history is related to the disease 
burden associated with breast cancer in a Chinese 
population.
 During the 1990s, progress in early detection 
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and treatment of breast cancer resulted in a 
decreasing mortality in Caucasian populations. 
Disparities in the disease incidence and mortality 
by age group were also observed. It is not known 
whether the same is found in non-Caucasian 
populations, such as the Chinese population in Hong 
Kong. This can be determined by investigation of the 
trend and projection for breast cancer mortality in 
Hong Kong.
 This study aimed to (1) examine the incidence 
trend using recently available population data and 
the APC model; (2) estimate the relative effects 
of age at diagnosis, period of diagnosis, and birth 
cohort on trends in breast cancer incidence and 
mortality using the APC model with reference to 
the life course theory; and (3) forecast the future 
trends for the short- to medium-term based on the 
extrapolation of trends in earlier periods.
Methods
This study was conducted from October 2012 to 
September 2013 and has been published elsewhere.4 
According to the International Classification of 
Diseases (ICD) codes of ICD-8 174, ICD-9 174, 
ICD-10 C50, and C50.0-C50.9, age-specific breast 
cancer incidence, mortality, and mid-year population 
figures from 1976 to 2010 were retrieved from the 
Hong Kong Cancer Registry, Hong Kong Death 
Registry, and the Census and Statistics Department, 
respectively. New cases and all deaths associated 
with breast cancer during the period were included. 
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of dying from it. This can be explained by early 
detection and the availability of better treatment.
5. The lower risk for women in the 1910s birth 
cohorts may reflect possible dietary restriction at 
early ages in the 1910s and the 1920s.
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Given that breast cancer incidence/mortality was 
not common for very young age groups, fourteen 
5-year age groups from 20-24 to ≥85 years, and 
seven 5-year periods from 1976-1980 to 2006-2010 
were classified.
 The age-adjusted incidence and mortality 
trends (per 100 000 women) in Hong Kong were 
calculated by a direct-standardisation method, 
according to the World Standard Population in 2000. 
By using Joinpoint regression analysis, the trends of 
breast cancer incidence and mortality from 1976 to 
2010 were characterised using segmented annual 
percentage changes and the overall percentage 
change (OPC).
 APC regression analysis and fitted Poisson 
regression models on the chronological age, calendar 
period, and birth cohort effects were conducted. 
Bayesian inference was applied to estimate the model 
parameters, and the fitted model was used to project 
future incidence/mortality in three 5-year periods 
up to 2025. The parameter estimates and the derived 
rates were summarised in terms of posterior means 
and 95% credible intervals. The model goodness-of-
fit was measured by the posterior mean deviance 
D. The resulting models were used to project age-
standardised breast cancer incidence and mortality 
in the short to medium term (until 2021-25). The 
uncertainty associated with our projections was 
quantified using 95% projection intervals. All 
analyses were implemented using Joinpoint 4.0.1, R 
version 2.10.1 and WinBUGS version 1.4.
Results
Temporal patterns in age-standardised 
incidence and mortality during 1976-2010 
and projections for 2011-2025
The changes in breast cancer incidence or mortality 
were quantified in terms of segmented annual 
percentage changes and OPCs (Fig 1). The fourth 
period centred at 1993 was marked by a joinpoint 
at which the slope changed significantly for both 
the incidence and mortality trends. The incidence 
increased significantly by 1.24% per year until the 
5-year period centred at 1993, and then increased 
further by 2.14% per year. In contrast, mortality 
increased by 0.35% per year until 1993, and then 
decreased significantly by 0.39% per year after 1993.
 The age-standardised annual incidence rose 
by a mean of 1.69% per year in the three decades 
between 1976 and 2010 (OPCincidence,1976-2010=1.69). 
The age-standardised breast cancer incidence 
was predicted to increase from 56.7 in 2011-15 to 
62.5 in 2021-25 per 100 000 women. In contrast, 
age-standardised annual mortality decreased by 
a mean of 0.03% per year between 1976 and 2010 
(OPCmortality,1976-2010=0.03). The rate was projected to 
decline from 9.3 in 2011-2015 to 8.6 in 2021-2025 
per 100 000 women. 
Age-period-cohort analyses of breast cancer 
incidence and mortality trends
The estimated parameter values of the age, period, 
and cohort components are shown in Fig 2. Due to 
the identifiability problem of the APC models, where 
the effects of the three components are linearly 
dependent, only second-order changes (ie changes 
in slopes or inflection points) were interpretable. 
Three inflection points for mortality and incidence 
trends were readily identified, while there were 
negligible second-order changes in period effects. 
In other words, cohort effects were significant in 
both incidence and mortality trends from 1976 to 
2010, but period effects were not significant. With 
respect to the inflection points for the two birth 
cohort curves, the first two inflection points (1910 
and 1930) coincided and the third inflection points 
for mortality and incidence birth cohort curves were 
different (1950 and 1960, respectively).
 Deviance information criteria for different 
combinations of age, period, and cohort effects were 
also estimated (data not shown). The full APC model 
provided the best fit with substantially smaller values 
of deviance information criteria compared with the 
other partial models. 
Trends in incidence and mortality by age 
group
Incidence trend was projected to increase into the 
near future for women older than 55 years. Mortality 
FIG 1.  Annual age-standardised female breast cancer incidence and mortality in 
Hong Kong from 1976 to 2010 and projected incidence and mortality (dotted lines) 
to 2025 with 95% credible intervals (grey area). The segmented annual percentage 
change (sAPC) was significantly different from zero (P<0.05), from which the period 
centred at 1993 (vertical dotted line) was marked by a joinpoint at which the slope 
changed significantly in both the incidence and mortality trends.
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trend was projected to decline in the near future for 
women aged <65 years but increase for those aged 
≥65 years.
Discussion
Our findings predict that breast cancer incidence 
will continue to increase at 0.65% per year, whereas 
mortality will decrease at 0.56% per year between 2010 
and 2025. Cumulatively, this represents a projected 
increase of 10.2% in incidence and a decrease of 7.5% 
in mortality. The incidence trends seem to have been 
driven mainly by ageing and birth cohort effects 
(ie the intergenerational effects were mainly driven 
by the post baby boomers), and there are no clear 
non-linear changes in trend by time-period effect. 
In contrast, the mortality trend has been relatively 
stable compared with the increasing incidence trend 
over the past three decades. The temporal trends in 
mortality might be explained by an improvement in 
survival due to better treatment for breast cancer and 
better responses to newly developed therapy such as 
paclitaxel use in the 1990s, and adjuvant hormonal 
and targeted immunotherapy in the 2000s. 
  Strong birth cohort trends were observed 
in breast cancer incidence and mortality, with 
inflection points around birth cohorts at 1910, 1930, 
FIG 2.  Parameter estimates of age, period, and cohort effects from two age-period-cohort models for female incidence and 
mortality trends related to breast cancer (deviance information criteria being 916.60 for incidence model and 737.44 for 
mortality model). Estimated age-specific annual female (a) incidence and (c) mortality related to breast cancer in 5-year age groups 
in Hong Kong with 95% credible intervals. Estimated relative risks for 10-year birth cohort (beginning from 1889) and 5-year 
period effects (beginning from 1976) associated with (b) incidence cases and (d) deaths with 95% credible intervals, including 
projected cohort effects for birth cohorts centred on the years 1993, 1998, and 2003 and projected period effects for periods 
centred on the years 2013, 2018, and 2023. 
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and 1960, and at 1910, 1930, and 1950, respectively. 
These effects could have been brought about by key 
historical events that altered the breast cancer risk 
factors at a population level. 
 Among the earliest birth cohorts, there was 
a deceleration in disease risk in incidence and 
mortality, especially in the 1910s birth cohorts. 
This trend coincided with the collapse of the Qing 
dynasty and a subsequent fall in living standards. 
The lower risk for these women might reflect 
possible dietary restriction at early ages in the first 
two decades after the revolution in 1911. Moreover, 
the increase in disease risk and mortality for the 
birth cohorts during the 1930s period coincided 
with the first cohort of women who migrated from 
China to Hong Kong. The mortality trend might 
reflect changes in incidence and poorer long-term 
survival in the period before World War II. The 
deceleration at around 1960 in birth cohort effects 
on the risk of developing the disease coincided with 
the last cohorts of women who had lived some years 
of their puberty in China. This generation of Hong 
Kong Chinese women grew up in a rapidly growing 
economy. Interestingly, the birth cohort around 
1960s was at higher risk of developing the disease 
but at lower risk of death than previous generations. 
This might be explained by early detection and the 
availability of better treatment.
 We projected a reduction in age-specific 
mortality for women aged ≤65 years, and a rising 
trend in mortality among women older than 65 
years during 2010-25. In comparison with western 
countries that have had major socioeconomic 
transition in the more distant past, a reduction 
in mortality trends is observed in the younger 
age group (<50 years) in Hong Kong, regardless 
of the national screening level in young women.5 
This relatively larger reduction may reflect more 
effective cancer treatment and better response to 
treatment.5 These same reasons could apply to the 
Hong Kong context. It is nonetheless unclear why 
mortality increased for much older women in Hong 
Kong. This could be attributed to a combination 
of less frequent diagnostic activity, less intensive 
treatment, and more frequent diagnosis of cancer at 
an advanced stage.5 Increased mortality projection 
in older women suggests a need to investigate the 
underlying reasons and extend access to better 
treatment and medical technologies for all segments 
of the population whenever applicable.  
 There were limitations to the study. APC 
analyses are descriptive in nature. We can only 
speculate the aetiology of the changes observed. 
Nonetheless, our analyses can generate hypotheses 
about the relationship between cancer disease risk 
and potential risk factors. The reliability of APC 
analyses depends on the quality of the incidence and 
mortality data. The Hong Kong Cancer Registry is 
the most carefully validated source of data. Quality 
indicators suggest that our data quality matches 
international standards.
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